MedTrace Logo

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate

NCT04656067 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2022-03-17

No results posted yet for this study

Summary

Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate, Pre-operative Administration.

Conditions

  • Blood Loss, Surgical
  • Blood Loss, Postoperative

Interventions

DRUG

Oxytocin ,Tranexamic acid and Ethamsylate

Is to compare blood loss during elective cesarean section intraoperative and postoperative in cases receiving Oxytocin versus Tranexamic acid and Ethamsylate

Sponsors & Collaborators

  • Egymedicalpedia

    lead INDUSTRY

Principal Investigators

  • Dr.,AbdelSattar M Farhan, Professor · Al-Azhar University, Faculty of medicine for boys

  • Dr.,ElSayed A. ElDesouky, Professor · Al-Azhar University, Faculty of medicine for boys

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-10-01
Completion
2020-11-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04656067 on ClinicalTrials.gov